Table 5.
—Risk Stratification for VTE in General, Abdominal-Pelvic, Bariatric, Vascular, and Plastic and Reconstructive Surgery
| Patient Population |
||||||||
| Patients Undergoing Major
General, Thoracic, or Vascular Surgery |
Patients Undergoing General
Surgery, Including GI, Urological, Vascular, Breast, and
Thyroid Procedures |
Patients Undergoing Plastic and
Reconstructive Surgery |
Other Surgical Populations in
Risk Category |
Estimated Baseline Risk in the
Absence of Pharmacologic or Mechanical Prophylaxis,
% |
||||
| AT9 VTE Risk Category | Rogers Score | Observed Risk of Symptomatic VTE, % | Caprini Score | Observed Risk of Symptomatic VTE, % | Caprini Score | Observed Risk of VTE, % | ||
| Very low |
< 7 |
0.1 |
0 |
0 |
0-2 |
NA |
Most outpatient or same-day surgery |
< 0.5 |
| Low |
7-10 |
0.4 |
1-2 |
0.7 |
3-4 |
0.6 |
Spinal surgery for nonmalignant disease |
1.5 |
| Moderate |
> 10 |
1.5 |
3-4 |
1.0 |
5-6 |
1.3 |
Gynecologic noncancer surgery Cardiac surgery Most thoracic
surgery Spinal surgery for malignant disease |
3.0 |
| High | NA | NA | ≥ 5 | 1.9 | 7-8 | 2.7 | Bariatric surgery Gynecologic cancer surgery PneumonectomyCraniotomy Traumatic brain injury Spinal cord injury Other major trauma | 6.0 |
AT9 = Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.